Julia Maslovskaja

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Jérémie Rosain et al. · Science Immunology · 2021 · 631 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes

Ana Rebane, Toomas Runnel, Alar Aab et al. · Journal of Allergy and Clinical Immunology · 2014 · 198 citations · Full text

Medicine, Dermatology, Immunology +16

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids

Piret Arukuusk, Ly Pärnaste, Nikita Oskolkov et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2013 · 93 citations

Pharmacy, Biotechnology, Molecular Biology +13

miR-146b Probably Assists miRNA-146a in the Suppression of Keratinocyte Proliferation and Inflammatory Responses in Psoriasis

Helen Hermann, Toomas Runnel, Alar Aab et al. · Journal of Investigative Dermatology · 2017 · 90 citations · Full text

Life Sciences, Dermatology, Molecular Biology +16